Systematic (IUPAC) name | |
---|---|
(7α,17β)-17-hydroxy-7,17-dimethylestr-4-en-3-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | ? |
Legal status | Schedule 3 (US) |
Routes | Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Half-life | 2-4 hours |
Identifiers | |
CAS number | 3704-09-4 |
ATC code | None |
PubChem | CID 251636 |
ChemSpider | 220460 |
UNII | 9OGY4BOR8D |
KEGG | D05025 |
ChEMBL | CHEMBL425863 |
Synonyms | (7R,8R,9S,10R,13S,14S,17S)-17-Hydroxy-7,13,17-trimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one |
Chemical data | |
Formula | C20H30O2 |
Mol. mass | 302.4558 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Mibolerone is a potent anabolic steroid which is both higher affinity[1] and more selective[2] for the androgen receptor than metribolone.
Under the brand name "Cheque Drops", Mibolerone was marketed as a veterinary drug by the Upjohn company. It was indicated as an oral treatment for estrous (heat) prevention in adult female dogs.